Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 16604193)


Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors.

Kakoki M, Kizer CM, Yi X, Takahashi N, Kim HS, Bagnell CR, Edgell CJ, Maeda N, Jennette JC, Smithies O.

J Clin Invest. 2006 May;116(5):1302-9. Epub 2006 Apr 6.


Late-intervention study with ebselen in an experimental model of type 1 diabetic nephropathy.

Tan SM, Sharma A, Stefanovic N, de Haan JB.

Free Radic Res. 2015 Mar;49(3):219-27. doi: 10.3109/10715762.2014.993628. Epub 2015 Jan 30.


The kinin B1 receptor regulates muscle-specific E3 ligases expression and is involved in skeletal muscle mass control.

Parreiras-E-Silva LT, Reis RI, Santos GA, Pires-Oliveira M, Pesquero JB, Gomes MD, Godinho RO, Costa-Neto CM.

Clin Sci (Lond). 2014 Aug;127(3):185-94. doi: 10.1042/CS20130358.


Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.

Koid SS, Ziogas J, Campbell DJ.

Hypertension. 2014 Apr;63(4):768-73. doi: 10.1161/HYPERTENSIONAHA.113.02902. Epub 2014 Jan 13.


Bradykinin inhibits oxidative stress-induced cardiomyocytes senescence via regulating redox state.

Dong R, Xu X, Li G, Feng W, Zhao G, Zhao J, Wang DW, Tu L.

PLoS One. 2013 Oct 25;8(10):e77034. doi: 10.1371/journal.pone.0077034. eCollection 2013.


Proteomic analysis of hearts from Akita mice suggests that increases in soluble epoxide hydrolase and antioxidative programming are key changes in early stages of diabetic cardiomyopathy.

Dewey S, Lai X, Witzmann FA, Sohal M, Gomes AV.

J Proteome Res. 2013 Sep 6;12(9):3920-33. doi: 10.1021/pr4004739. Epub 2013 Aug 2.


Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice.

Shi Y, Lo CS, Chenier I, Maachi H, Filep JG, Ingelfinger JR, Zhang SL, Chan JS.

Am J Physiol Renal Physiol. 2013 Jun 1;304(11):F1335-46. doi: 10.1152/ajprenal.00405.2012. Epub 2013 Apr 3.


Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina.

McLenachan S, Chen X, McMenamin PG, Rakoczy EP.

Clin Experiment Ophthalmol. 2013 Aug;41(6):582-92. doi: 10.1111/ceo.12084. Epub 2013 May 21.


Bradykinin B2 receptor contributes to the exaggerated muscle mechanoreflex in rats with femoral artery occlusion.

Lu J, Xing J, Li J.

Am J Physiol Heart Circ Physiol. 2013 Apr 15;304(8):H1166-74. doi: 10.1152/ajpheart.00926.2012. Epub 2013 Feb 15.


Novel insights into the critical role of bradykinin and the kinin B2 receptor for vascular recruitment of circulating endothelial repair-promoting mononuclear cell subsets: alterations in patients with coronary disease.

Kränkel N, Kuschnerus K, Müller M, Speer T, Mocharla P, Madeddu P, Bader M, Lüscher TF, Landmesser U.

Circulation. 2013 Feb 5;127(5):594-603. doi: 10.1161/CIRCULATIONAHA.112.118117. Epub 2012 Dec 30.


Global renal gene expression profiling analysis in B2-kinin receptor null mice: impact of diabetes.

Jaffa MA, Kobeissy F, Al Hariri M, Chalhoub H, Eid A, Ziyadeh FN, Jaffa AA.

PLoS One. 2012;7(9):e44714. doi: 10.1371/journal.pone.0044714. Epub 2012 Sep 18.


Null mutations at the p66 and bradykinin 2 receptor loci induce divergent phenotypes in the diabetic kidney.

Vashistha H, Singhal PC, Malhotra A, Husain M, Mathieson P, Saleem MA, Kuriakose C, Seshan S, Wilk A, Delvalle L, Peruzzi F, Giorgio M, Pelicci PG, Smithies O, Kim HS, Kakoki M, Reiss K, Meggs LG.

Am J Physiol Renal Physiol. 2012 Dec 15;303(12):F1629-40. doi: 10.1152/ajprenal.00246.2012. Epub 2012 Sep 26.


Assessment of diabetic nephropathy in the Akita mouse.

Chang JH, Gurley SB.

Methods Mol Biol. 2012;933:17-29. doi: 10.1007/978-1-62703-068-7_2.


Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse.

Liu GC, Fang F, Zhou J, Koulajian K, Yang S, Lam L, Reich HN, John R, Herzenberg AM, Giacca A, Oudit GY, Scholey JW.

Diabetologia. 2012 Sep;55(9):2522-32. doi: 10.1007/s00125-012-2586-1. Epub 2012 Jun 1.


Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor.

Blaes N, Pécher C, Mehrenberger M, Cellier E, Praddaude F, Chevalier J, Tack I, Couture R, Girolami JP.

Am J Physiol Renal Physiol. 2012 Jul 15;303(2):F293-303. doi: 10.1152/ajprenal.00437.2011. Epub 2012 May 9.


Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis.

Patel VB, Bodiga S, Basu R, Das SK, Wang W, Wang Z, Lo J, Grant MB, Zhong J, Kassiri Z, Oudit GY.

Circ Res. 2012 May 11;110(10):1322-35. doi: 10.1161/CIRCRESAHA.112.268029. Epub 2012 Apr 3.


The kallikrein-kinin system in diabetic nephropathy.

Tomita H, Sanford RB, Smithies O, Kakoki M.

Kidney Int. 2012 Apr;81(8):733-44. doi: 10.1038/ki.2011.499. Epub 2012 Feb 8. Review.


Mitochondrial redox studies of oxidative stress in kidneys from diabetic mice.

Maleki S, Sepehr R, Staniszewski K, Sheibani N, Sorenson CM, Ranji M.

Biomed Opt Express. 2012 Feb 1;3(2):273-81. doi: 10.1364/BOE.3.000273. Epub 2012 Jan 10.


Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.

Lo CS, Liu F, Shi Y, Maachi H, Chenier I, Godin N, Filep JG, Ingelfinger JR, Zhang SL, Chan JS.

Am J Physiol Renal Physiol. 2012 Apr 1;302(7):F840-52. doi: 10.1152/ajprenal.00340.2011. Epub 2011 Dec 28.


Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2.

Chang SY, Chen YW, Chenier I, Tran Sle M, Zhang SL.

Exp Diabetes Res. 2011;2011:521076. doi: 10.1155/2011/521076. Epub 2011 Oct 27.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk